JPWO2023167880A5 - - Google Patents
Info
- Publication number
- JPWO2023167880A5 JPWO2023167880A5 JP2024552144A JP2024552144A JPWO2023167880A5 JP WO2023167880 A5 JPWO2023167880 A5 JP WO2023167880A5 JP 2024552144 A JP2024552144 A JP 2024552144A JP 2024552144 A JP2024552144 A JP 2024552144A JP WO2023167880 A5 JPWO2023167880 A5 JP WO2023167880A5
- Authority
- JP
- Japan
- Prior art keywords
- och
- item
- mrna sequence
- independently
- motif
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263315323P | 2022-03-01 | 2022-03-01 | |
| US63/315,323 | 2022-03-01 | ||
| US202363485753P | 2023-02-17 | 2023-02-17 | |
| US63/485,753 | 2023-02-17 | ||
| PCT/US2023/014183 WO2023167880A2 (en) | 2022-03-01 | 2023-02-28 | Compositions and methods for capping rnas |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025507894A JP2025507894A (ja) | 2025-03-21 |
| JPWO2023167880A5 true JPWO2023167880A5 (https=) | 2026-03-10 |
| JP2025507894A5 JP2025507894A5 (https=) | 2026-03-10 |
Family
ID=87884204
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024552144A Pending JP2025507894A (ja) | 2022-03-01 | 2023-02-28 | Ｒｎａをキャッピングするための組成物及び方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250084409A1 (https=) |
| EP (1) | EP4486355A4 (https=) |
| JP (1) | JP2025507894A (https=) |
| CN (1) | CN119137271A (https=) |
| WO (1) | WO2023167880A2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4733306A1 (en) * | 2023-06-26 | 2026-04-29 | Elonova Co., Ltd. | Novel modified trinucleotide capping derivative, and mrna into which capping derivative is introduced |
| IL326531A (en) * | 2023-09-06 | 2026-04-01 | Trilink Biotechnologies Llc | Cap analogues and methods of their use |
| CN116987137B (zh) * | 2023-09-26 | 2024-01-02 | 江苏申基生物科技有限公司 | 一种加帽化合物及其在mRNA加帽中的应用 |
| WO2025168058A1 (zh) * | 2024-02-08 | 2025-08-14 | 江苏申基生物科技有限公司 | 新的mRNA加帽化合物及其应用 |
| WO2026009929A1 (ja) * | 2024-07-03 | 2026-01-08 | 富士フイルム株式会社 | 化合物、ｒｎａ合成開始剤、およびそれらの利用 |
| CN119306779A (zh) * | 2024-12-13 | 2025-01-14 | 上海科泽永欣生物科技有限公司 | 一种含r构型的起始加帽寡核苷酸引物及其合成方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2964690T3 (es) * | 2015-09-21 | 2024-04-09 | Trilink Biotechnologies Llc | Método para sintetizar ARN con caperuza 5' |
| US11866754B2 (en) * | 2015-10-16 | 2024-01-09 | Modernatx, Inc. | Trinucleotide mRNA cap analogs |
| WO2017098468A1 (en) * | 2015-12-09 | 2017-06-15 | Novartis Ag | Label-free analysis of rna capping efficiency using rnase h, probes and liquid chromatography/mass spectrometry |
| PL415967A1 (pl) * | 2016-01-29 | 2017-07-31 | Univ Warszawski | 5'-tiofosforanowe analogi końca 5' mRNA (kapu), sposób ich otrzymywania i zastosowanie |
| US10487105B2 (en) * | 2016-10-19 | 2019-11-26 | Arcturus Therapeutics, Inc. | Trinucleotide MRNA cap analogs |
| KR20200143391A (ko) * | 2018-03-15 | 2020-12-23 | 비온테크 알엔에이 파마슈티컬스 게엠베하 | 5'-캡-트리뉴클레오티드- 또는 고차의 올리고뉴클레오티드 화합물 및 이들의 rna 안정화, 단백질 발현 및 치료에서의 사용 |
| PL432884A1 (pl) * | 2020-02-12 | 2021-08-16 | Uniwersytet Warszawski | Nowe analogi kapu końca 5' mRNA, cząsteczka RNA je zawierająca, ich zastosowania i sposób syntezy cząsteczki RNA i peptydu |
| PL248416B1 (pl) * | 2020-02-12 | 2025-12-08 | Explorna Therapeutics Spolka Z Ograniczona Odpowiedzialnoscia | Nowe analogi kapu końca 5’ mRNA, cząsteczka RNA je zawierająca, ich zastosowania i sposób syntezy cząsteczki RNA i peptydu |
| CN116368226A (zh) * | 2020-09-04 | 2023-06-30 | 维乎医疗有限公司 | 用于加帽rna的组合物和方法 |
| US20250108066A1 (en) * | 2022-01-27 | 2025-04-03 | Trilink Biotechnologies, Llc | Trinucleotide cap analogs and methods of use thereof |
-
2023
- 2023-02-28 JP JP2024552144A patent/JP2025507894A/ja active Pending
- 2023-02-28 EP EP23763863.0A patent/EP4486355A4/en active Pending
- 2023-02-28 WO PCT/US2023/014183 patent/WO2023167880A2/en not_active Ceased
- 2023-02-28 CN CN202380034551.7A patent/CN119137271A/zh active Pending
-
2024
- 2024-11-25 US US18/819,275 patent/US20250084409A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12103944B2 (en) | Compositions and methods for synthesizing 5′-capped RNAs | |
| JPWO2022051677A5 (https=) | ||
| JP2021169466A (ja) | テロメラーゼ阻害のための改変オリゴヌクレオチド | |
| JP2003532643A (ja) | 肝炎ウイルス感染症を治療するための３’−または２’−ヒドロキシメチル置換ヌクレオシド誘導体 | |
| JPWO2023167880A5 (https=) | ||
| KR20230123318A (ko) | 5'-캡핑된 rna 합성용 올리고뉴클레오티드 | |
| JP7723848B2 (ja) | ｍＲＮＡキャップ類似体及びその用途 | |
| AU2024351425C1 (en) | Mrna cap analog and use thereof | |
| CA3253482C (en) | Mrna cap analog and uses thereof | |
| KR20230083197A (ko) | 5'-캡핑된 rna 합성용 올리고뉴클레오티드 | |
| HK40080484A (en) | Method for synthesizing 5'-capped rnas | |
| HK40111373A (en) | Compositions and methods for synthesizing 5'-capped rnas | |
| HK40075972A (en) | Compositions and methods for synthesizing 5-capped rnas | |
| HK40068780A (en) | Compositions and methods for synthesizing 5'-capped rnas | |
| CA3253482A1 (en) | Mrna cap analog and uses thereof | |
| HK40068021A (en) | Initiating capped oligonucleotide primers for synthesizing 5'-capped rnas | |
| HK40054592A (en) | Initiating capped oligonucleotide primers for synthesizing 5'-capped rnas | |
| HK40080484B (en) | Method for synthesizing 5'-capped rnas | |
| HK40111373B (en) | Compositions and methods for synthesizing 5'-capped rnas | |
| HK40075972B (en) | Compositions and methods for synthesizing 5-capped rnas | |
| CN118974071A (zh) | mRNA帽类似物及其用途 | |
| HK40054592B (en) | Initiating capped oligonucleotide primers for synthesizing 5'-capped rnas |